DK610888A - Cardiodilatinfragmentet, fremgangsmaade til fremstilling deraf samt dets anvendelse - Google Patents

Cardiodilatinfragmentet, fremgangsmaade til fremstilling deraf samt dets anvendelse

Info

Publication number: DK610888A
Authority: DK; Denmark
Prior art keywords: anf; cdd; arg; ser; preparing
Prior art date: 1987-03-02

Application number

DK610888A

Other languages

English (en)

Other versions

DK610888D0 (da

DK174112B1 (da

Inventor

Wolf-Georg Forssmann

Jeanette M Alt

Gerhard Becker

Franz Herbst

Original Assignee

Bissendorf Peptide Gmbh

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1987-03-02

Filing date

1988-11-02

Publication date

1988-11-02

1987-03-02 Priority claimed from DE19873706731 external-priority patent/DE3706731A1/de

1987-05-22 Priority claimed from DE19873717329 external-priority patent/DE3717329A1/de

1988-11-02 Application filed by Bissendorf Peptide Gmbh filed Critical Bissendorf Peptide Gmbh

1988-11-02 Publication of DK610888A publication Critical patent/DK610888A/da

1988-11-02 Publication of DK610888D0 publication Critical patent/DK610888D0/da

2002-06-24 Application granted granted Critical

2002-06-24 Publication of DK174112B1 publication Critical patent/DK174112B1/da

Links

239000004615 ingredient Substances 0.000 title 1
108010033276 Peptide Fragments Proteins 0.000 abstract 3
102000007079 Peptide Fragments Human genes 0.000 abstract 3
102400001279 Urodilatin Human genes 0.000 abstract 3
150000001413 amino acids Chemical group 0.000 abstract 3
IUCCYQIEZNQWRS-DWWHXVEHSA-N ularitide Chemical compound C([C@H]1C(=O)NCC(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@H](C(NCC(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CSSC[C@@H](C(=O)N1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](C)NC(=O)[C@@H](N)[C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(O)=O)=O)[C@@H](C)CC)C1=CC=CC=C1 IUCCYQIEZNQWRS-DWWHXVEHSA-N 0.000 abstract 3
108010001957 Ularitide Proteins 0.000 abstract 2
239000003814 drug Substances 0.000 abstract 2
229940079593 drug Drugs 0.000 abstract 2
101800001849 Urodilatin Proteins 0.000 abstract 1
239000012634 fragment Substances 0.000 abstract 1
210000003734 kidney Anatomy 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/58—Atrial natriuretic factor complex; Atriopeptin; Atrial natriuretic peptide [ANP]; Cardionatrin; Cardiodilatin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/02—Antidotes
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Public Health (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Cardiology (AREA)
Toxicology (AREA)
Heart & Thoracic Surgery (AREA)
Gastroenterology & Hepatology (AREA)
Endocrinology (AREA)
Obesity (AREA)
Genetics & Genomics (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Ophthalmology & Optometry (AREA)
Hematology (AREA)
Reproductive Health (AREA)
Diabetes (AREA)
Zoology (AREA)
Biochemistry (AREA)
Biophysics (AREA)
Biomedical Technology (AREA)
Molecular Biology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Dermatology (AREA)
Urology & Nephrology (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Peptides Or Proteins (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)

DK198806108A 1987-03-02 1988-11-02 Cardiodilatinfragment benævnt urodilatin, fremgangsmåde til fremstilling deraf, lægemiddel indeholdende det, fremgangsmåde til bestemmelse af cardiodilatin samt anvendelse af urodilatin til fremstilling af diagnostika samt til fremstilling af lægemidler DK174112B1 (da)

Applications Claiming Priority (8)

Application Number	Priority Date	Filing Date	Title
DE3706731		1987-03-02
DE19873706731 DE3706731A1 (de)	1987-03-02	1987-03-02	Neues cardiodilatinfragment und verfahren zur gewinnung von cardiodilatinfragmenten
DE19873717329 DE3717329A1 (de)	1987-05-22	1987-05-22	Neues cardiodilatinfragment, verfahren zu seiner gewinnung und seine verwendung
DE3717329		1987-05-22
DE3741641		1987-12-09
DE3741641		1987-12-09
PCT/EP1988/000144 WO1988006596A1 (en)	1987-03-02	1988-02-27	New cardiodilatin fragment, process for preparing same and use thereof
EP8800144		1988-02-27

Publications (3)

Publication Number	Publication Date
DK610888A true DK610888A (da)	1988-11-02
DK610888D0 DK610888D0 (da)	1988-11-02
DK174112B1 DK174112B1 (da)	2002-06-24

Family

ID=27195544

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK198806108A DK174112B1 (da)	1987-03-02	1988-11-02	Cardiodilatinfragment benævnt urodilatin, fremgangsmåde til fremstilling deraf, lægemiddel indeholdende det, fremgangsmåde til bestemmelse af cardiodilatin samt anvendelse af urodilatin til fremstilling af diagnostika samt til fremstilling af lægemidler

Country Status (7)

Country	Link
EP (1)	EP0349545B1 (da)
JP (1)	JP2819467B2 (da)
AT (1)	ATE85345T1 (da)
AU (1)	AU614738B2 (da)
DE (1)	DE3878231T2 (da)
DK (1)	DK174112B1 (da)
WO (1)	WO1988006596A1 (da)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5262521A (en) *	1991-06-07	1993-11-16	Sri International	Isolated atrial peptide-degrading enzyme and novel compounds useful as inhibitors thereof
DE4216133A1 (de) *	1992-05-15	1993-11-18	Bissendorf Peptide Gmbh	Anwendung von Urodilatin bei Lungen- und Bronchialerkrankungen
US5665704A (en) *	1993-11-12	1997-09-09	Genentech, Inc.	Receptor specific atrial natriuretic peptides
US6525022B1 (en)	1993-11-12	2003-02-25	Genentech, Inc.	Receptor specific atrial natriuretic peptides
US5846932A (en) *	1993-11-12	1998-12-08	Genentech, Inc.	Receptor specific atrial natriuretic peptides
AU2671795A (en) *	1994-06-02	1996-01-04	Boehringer Mannheim Gmbh	Process and intermediate products for preparing cardiodilatin fragments, and highly purified cardiodilatin fragments
DE19535445A1 (de) *	1995-09-23	1997-03-27	Boehringer Mannheim Gmbh	Verfahren zur Herstellung von natriuretischen Peptiden über Streptavidin-Fusionsproteine
WO1997018314A1 (de) *	1995-11-16	1997-05-22	Boehringer Mannheim Gmbh	Verfahren zur herstellung von peptiden über streptavidin-fusionsproteine
DE19951471A1 (de) *	1999-10-26	2001-05-03	Forssmann Wolf Georg	Verwendung von Urodilatin zur Behandlung chronischer Niereninsuffizienz mit Nierenrestfunktionen
DE10116552A1 (de)	2001-04-03	2002-10-10	Abc Armbruster Biochemicals	Verfahren zur Bestimmung der wirksamen Parathormon-Aktivität in einer Probe
PL1865976T3 (pl)	2005-04-07	2012-11-30	Cardiorentis Ag	Zastosowanie peptydu natriuretycznego do leczenia niewydolności serca
EP2004633A4 (en)	2006-03-30	2009-08-26	Palatin Technologies Inc	LINEAR NATRIURETIC PEPTIDE CONSTRUCTS
CA2647143A1 (en)	2006-03-30	2007-10-11	Palatin Technologies, Inc.	Cyclic natriuretic peptide constructs
US8580746B2 (en)	2006-03-30	2013-11-12	Palatin Technologies, Inc.	Amide linkage cyclic natriuretic peptide constructs
EP2185183B1 (en) *	2007-09-11	2016-03-16	Cardiopep Pharma GmbH	Use of natriuretic peptides for treating angioedema syndromes
EP2631247A1 (en)	2012-02-22	2013-08-28	Immundiagnostik AG	Means and methods of measuring parathyroid hormone in patients suffering from oxidative stress
EP2775306B1 (en)	2013-03-08	2018-06-27	Immundiagnostik AG	Non-oxidized, biological active parathyroid hormone determines mortality in hemodialysis patients
WO2019141791A1 (en)	2018-01-17	2019-07-25	Immundiagnostik Ag	Biomarker predicting coronary artery disease
FR3099056B1 (fr) *	2019-07-26	2022-08-12	Univ Rouen Normandie	Utilisation de l’ANP pour détruire les biofilms bactériens

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE3588006T2 (de) *	1984-04-19	1995-08-10	Scios Nova Inc	Atrielle natriumuretische/gefässerweiterende polypeptide.
DE3443257A1 (de) *	1984-11-28	1986-05-28	Bissendorf Peptide GmbH, 3002 Wedemark	Mittel enthaltend vollsynthetisches alpha-humanes atriales natriuretisches peptid (alpha-hanap)

1988
- 1988-02-27 WO PCT/EP1988/000144 patent/WO1988006596A1/en not_active Ceased
- 1988-02-27 DE DE8888901838T patent/DE3878231T2/de not_active Expired - Lifetime
- 1988-02-27 AU AU13481/88A patent/AU614738B2/en not_active Expired
- 1988-02-27 JP JP63502001A patent/JP2819467B2/ja not_active Expired - Lifetime
- 1988-02-27 AT AT88901838T patent/ATE85345T1/de not_active IP Right Cessation
- 1988-02-27 EP EP88901838A patent/EP0349545B1/en not_active Expired - Lifetime
- 1988-11-02 DK DK198806108A patent/DK174112B1/da not_active IP Right Cessation

Also Published As

Publication number	Publication date
JP2819467B2 (ja)	1998-10-30
AU1348188A (en)	1988-09-26
EP0349545A1 (en)	1990-01-10
JPH02502636A (ja)	1990-08-23
WO1988006596A1 (en)	1988-09-07
EP0349545B1 (en)	1993-02-03
ATE85345T1 (de)	1993-02-15
DE3878231T2 (de)	1993-05-27
AU614738B2 (en)	1991-09-12
DK610888D0 (da)	1988-11-02
DK174112B1 (da)	2002-06-24
DE3878231D1 (de)	1993-03-18

Legal Events

Date	Code	Title	Description
2002-06-24	B1	Patent granted (law 1993)
2003-09-22	PBP	Patent lapsed	Country of ref document: DK

Publication	Publication Date	Title
DK610888A (da)	1988-11-02	Cardiodilatinfragmentet, fremgangsmaade til fremstilling deraf samt dets anvendelse
BR9710452A (pt)	1999-08-17	Anïïlogos de exendina processos para sua prepara-Æo e medicamentos contendo os mesmos
RU95115239A (ru)	1997-03-27	Аналог эритропоэтина
NO177678C (no)	1995-11-01	Fremgangsmåte for fremstilling av et terapeutisk aktivt, rekombinant protein som har ASP-aktivitet, ekspresjonssystem samt DNA som koder for nevnte protein
CA2080462A1 (en)	1991-10-12	Therapeutic uses of actin-binding compounds
EP1225225A3 (en)	2003-01-08	Osteogenic devices
ES8705919A1 (es)	1987-05-16	Un metodo para obtener un polipeptido complementario de al menos una porcion de un peptido o proteina original.
JPS6486896A (en)	1989-03-31	Method for isolating basic protein from protein mixture containing the basic protein
NO960309L (no)	1996-01-25	Agonister og antagonister for humaninterleukin-10
NZ232337A (en)	1991-09-25	Nonglycosylated tpa fragment (355 or 356 residues)
DK0479948T3 (da)	1999-05-25	Sammensætninger og fremgangsmåder til syntese af natriuretisk protein-receptor B og anvendelsesfremgangsmåder
GB9219936D0 (en)	1992-11-04	Vaccines
DK1025236T3 (da)	2005-10-24	Human checkpoint kinase, HCDS1, præparater og fremgangsmåde
DK611386A (da)	1987-02-18	Recombinant humant fsh, fremgangsmaade til fremstilling deraf og vektorer og celler til anvendelse ved fremgangsmaaden
EP0331755A4 (en)	1990-12-05	Medicine-containing fat emulsion of the type prepared immediately before use and process for preparing medicine-containing fat emulsion
DE3683447D1 (de)	1992-02-27	Verfahren zur herstellung von humanlysozym.
ATE260342T1 (de)	2004-03-15	Weidelgraspollen-allergen
NZ335633A (en)	2000-10-27	Production of recombinant H. pylori polypeptides for treatment and diagnosis of H. pylori related diseases
EP1132402A4 (en)	2005-12-21	PEPTIDE FRAGMENTS WITH CELL DEATH PREVENTIVE ACTIVITY
AU3595489A (en)	1989-12-07	Amblyommin, a new active substance for anticoagulant therapy
DE3584029D1 (de)	1991-10-17	Expressionsvektoren, dns-fragmente, peptide, wirte und verfahren zur herstellung von peptiden.
DK0616642T3 (da)	1997-07-07	Hidtil ukendte thrombininhibitoriske proteiner fra landblodigler
EP0780472A3 (en)	1998-05-20	Stress proteins
AR018532A1 (es)	2001-11-28	Proteinas sustancialmente puras que contienen analogos de la beta-lipoproteina (blt); aislados de acidos nucleicos que codifican dichas proteinas yformulaciones farmaceuticas que comprenden las proteinas
KR880011200A (ko)	1988-10-27	텐다미스탵 유도체